Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Coppola

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Respiratory Medicine|June 23, 2019
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patientsPaola Rogliani, Maria Gabriella Matera, Luigino Calzetta, et al.
Journal of Clinical Medicine|January 10, 2026
Cardiac Overload and Heart Failure Risk by NT-proBNP Levels in Older Adults with COPD Eligible for Single-Inhaler Triple Therapy: A Multicenter Longitudinal StudyRiccardo Sarzani, Francesco Spannella, Giorgia Laureti, et al.
Advances in Respiratory Medicine|March 24, 2026
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World StudyLorenzo Carriera, Angelo Coppola, Roberto Lipsi, et al.
Current Allergy and Asthma Reports|May 16, 2026
Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic ReviewPier-Valerio Mari, Lorenzo Carriera, Angela Saviano, et al.
Current Allergy and Asthma Reports|April 16, 2026
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical EvidencePier-Valerio Mari, Lorenzo Carriera, Simone Ielo, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 4, 2014
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in ItalyNera Agabiti, Maria Assunta Porretta, Lisa Bauleo, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Respiratory Medicine|June 23, 2019
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patientsPaola Rogliani, Maria Gabriella Matera, Luigino Calzetta, et al.
Journal of Clinical Medicine|January 10, 2026
Cardiac Overload and Heart Failure Risk by NT-proBNP Levels in Older Adults with COPD Eligible for Single-Inhaler Triple Therapy: A Multicenter Longitudinal StudyRiccardo Sarzani, Francesco Spannella, Giorgia Laureti, et al.
Advances in Respiratory Medicine|March 24, 2026
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World StudyLorenzo Carriera, Angelo Coppola, Roberto Lipsi, et al.
Current Allergy and Asthma Reports|May 16, 2026
Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic ReviewPier-Valerio Mari, Lorenzo Carriera, Angela Saviano, et al.
Current Allergy and Asthma Reports|April 16, 2026
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical EvidencePier-Valerio Mari, Lorenzo Carriera, Simone Ielo, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 4, 2014
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in ItalyNera Agabiti, Maria Assunta Porretta, Lisa Bauleo, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 4